128 related articles for article (PubMed ID: 22204653)
1. Mining the gastric cancer secretome: identification of GRN as a potential diagnostic marker for early gastric cancer.
Loei H; Tan HT; Lim TK; Lim KH; So JB; Yeoh KG; Chung MC
J Proteome Res; 2012 Mar; 11(3):1759-72. PubMed ID: 22204653
[TBL] [Abstract][Full Text] [Related]
2. A novel screening biomarker in gastric cancer: serum Dickkopf-1.
Gomceli I; Bostanci EB; Ozer I; Kemik AS; Turhan N; Tez M; Kilic S; Demiriz B; Akoglu M
Hepatogastroenterology; 2012; 59(117):1661-4. PubMed ID: 22155860
[TBL] [Abstract][Full Text] [Related]
3. Identification of matrix metalloproteinase 11 as a predictive tumor marker in serum based on gene expression profiling.
Yang YH; Deng H; Li WM; Zhang QY; Hu XT; Xiao B; Zhu HH; Geng PL; Lu YY
Clin Cancer Res; 2008 Jan; 14(1):74-81. PubMed ID: 18172255
[TBL] [Abstract][Full Text] [Related]
4. Identification of 14-3-3β in human gastric cancer cells and its potency as a diagnostic and prognostic biomarker.
Tseng CW; Yang JC; Chen CN; Huang HC; Chuang KN; Lin CC; Lai HS; Lee PH; Chang KJ; Juan HF
Proteomics; 2011 Jun; 11(12):2423-39. PubMed ID: 21598387
[TBL] [Abstract][Full Text] [Related]
5. Soluble E-cadherin is an independent pretherapeutic factor for long-term survival in gastric cancer.
Chan AO; Chu KM; Lam SK; Wong BC; Kwok KF; Law S; Ko S; Hui WM; Yueng YH; Wong J
J Clin Oncol; 2003 Jun; 21(12):2288-93. PubMed ID: 12805328
[TBL] [Abstract][Full Text] [Related]
6. Proteomic analysis of conditioned media from the PC3, LNCaP, and 22Rv1 prostate cancer cell lines: discovery and validation of candidate prostate cancer biomarkers.
Sardana G; Jung K; Stephan C; Diamandis EP
J Proteome Res; 2008 Aug; 7(8):3329-38. PubMed ID: 18578523
[TBL] [Abstract][Full Text] [Related]
7. Serum hyaluronic acid and laminin as potential tumor markers for upper gastrointestinal cancers.
Aghcheli K; Parsian H; Qujeq D; Talebi M; Mosapour A; Khalilipour E; Islami F; Semnani S; Malekzadeh R
Eur J Intern Med; 2012 Jan; 23(1):58-64. PubMed ID: 22153533
[TBL] [Abstract][Full Text] [Related]
8. Plasma matrix metalloproteinase-9 level is better than serum matrix metalloproteinase-9 level to predict gastric cancer evolution.
Wu CY; Wu MS; Chiang EP; Chen YJ; Chen CJ; Chi NH; Shih YT; Chen GH; Lin JT
Clin Cancer Res; 2007 Apr; 13(7):2054-60. PubMed ID: 17404086
[TBL] [Abstract][Full Text] [Related]
9. Lectin capture strategy for effective analysis of cell secretome.
Zhang Y; Tang X; Yao L; Chen K; Jia W; Hu X; Xu LX
Proteomics; 2012 Jan; 12(1):32-6. PubMed ID: 22065611
[TBL] [Abstract][Full Text] [Related]
10. Receiver operating characteristic (ROC) curve analysis of the tumor markers CEA, CA 19-9 and CA 72-4 in gastric cancer.
Fernández-Fernández L; Tejero E; Tieso A; Rabadán L; Munoz M; Santos I
Int Surg; 1996; 81(4):400-2. PubMed ID: 9127805
[TBL] [Abstract][Full Text] [Related]
11. Serum interleukin-6 levels reflect disease status of gastric cancer.
Wu CW; Wang SR; Chao MF; Wu TC; Lui WY; P'eng FK; Chi CW
Am J Gastroenterol; 1996 Jul; 91(7):1417-22. PubMed ID: 8678006
[TBL] [Abstract][Full Text] [Related]
12. IPO-38 is identified as a novel serum biomarker of gastric cancer based on clinical proteomics technology.
Hao Y; Yu Y; Wang L; Yan M; Ji J; Qu Y; Zhang J; Liu B; Zhu Z
J Proteome Res; 2008 Sep; 7(9):3668-77. PubMed ID: 18680356
[TBL] [Abstract][Full Text] [Related]
13. CEACAM1, a novel serum biomarker for pancreatic cancer.
Simeone DM; Ji B; Banerjee M; Arumugam T; Li D; Anderson MA; Bamberger AM; Greenson J; Brand RE; Ramachandran V; Logsdon CD
Pancreas; 2007 May; 34(4):436-43. PubMed ID: 17446843
[TBL] [Abstract][Full Text] [Related]
14. Serum soluble vascular adhesion protein-1 is a valuable prognostic marker in gastric cancer.
Yasuda H; Toiyama Y; Ohi M; Mohri Y; Miki C; Kusunoki M
J Surg Oncol; 2011 Jun; 103(7):695-9. PubMed ID: 21308684
[TBL] [Abstract][Full Text] [Related]
15. Is SCUBE 1 a new biomarker for gastric cancer?
Mentese A; Fidan E; Sumer AU; Karahan SC; Sonmez M; Altay DU; Kavgaci H; Alver A
Cancer Biomark; 2012; 11(5):191-5. PubMed ID: 23220851
[TBL] [Abstract][Full Text] [Related]
16. Serum tumor antigen REG4 as a useful diagnostic biomarker in gastric cancer.
Kobayashi Y; Niwa Y; Tajika M; Kawai H; Kondo S; Hara K; Mizuno N; Hijioka S; Sawaki A; Matsuo K; Nakagawa H; Nakamura Y; Yamao K
Hepatogastroenterology; 2010; 57(104):1631-4. PubMed ID: 21443133
[TBL] [Abstract][Full Text] [Related]
17. Circulating level of hepatocyte growth factor as a useful tumor marker in patients with early-stage gastric carcinoma.
Tanaka K; Miki C; Wakuda R; Kobayashi M; Tonouchi H; Kusunoki M
Scand J Gastroenterol; 2004 Aug; 39(8):754-60. PubMed ID: 15513361
[TBL] [Abstract][Full Text] [Related]
18. Identification of collapsin response mediator protein-2 as a potential marker of colorectal carcinoma by comparative analysis of cancer cell secretomes.
Wu CC; Chen HC; Chen SJ; Liu HP; Hsieh YY; Yu CJ; Tang R; Hsieh LL; Yu JS; Chang YS
Proteomics; 2008 Jan; 8(2):316-32. PubMed ID: 18203259
[TBL] [Abstract][Full Text] [Related]
19. Plasma adiponectin and gastric cancer.
Ishikawa M; Kitayama J; Kazama S; Hiramatsu T; Hatano K; Nagawa H
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):466-72. PubMed ID: 15701829
[TBL] [Abstract][Full Text] [Related]
20. Analysis of secreted proteins for the study of bladder cancer cell aggressiveness.
Makridakis M; Roubelakis MG; Bitsika V; Dimuccio V; Samiotaki M; Kossida S; Panayotou G; Coleman J; Candiano G; Anagnou NP; Vlahou A
J Proteome Res; 2010 Jun; 9(6):3243-59. PubMed ID: 20423150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
